Clinical and Economic Burden of Cytomegalovirus (CMV) Infection/Disease Among Hospitalized Adult Allogeneic Hematopoietic Stem Cell Transplant (Allo‐HSCT) Recipients in China
Rattachement africain : cn, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Cytomegalovirus (CMV) infection is a prevalent complication among allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients, posing significantly impact on clinical outcomes and healthcare costs. This study aims to assess the clinical and economic burden of CMV infection in hospitalized adult allo-HSCT recipients in China. A retrospective analysis was conducted using electronic medical records from two tertiary hospitals in China. A total of 1977 patients who underwent allo-HSCT while hospitalized between 1 January 2016 and 31 December 2021 were included in the study and followed up for 180 days. Data on CMV clinical characteristics, hospitalization duration, complications, and healthcare costs were collected and analyzed. CMV infection/disease was observed in 542 patients during the hospitalization of the allo-HSCT procedure, leading to longer hospital stays (69.36 [SD 23.15] vs 37.77 [SD 13.22] days, p < 0.001) and increased medical expenses (US$60,152.98 [SD 30,190.82] vs $34,430.88 [17,723.65], p < 0.001). Patients with CMV infection/disease had higher rates of complications, such as graft-versus-host disease (52.21% vs 19.65%, p < 0.001), and required more extensive use of granulocyte colony-stimulating factor, red blood cell and platelet transfusion, antifungals drugs, and antibacterials drugs. CMV infection/disease imposes significant clinical and economic burdens on hospitalized allo-HSCT recipients in China. Effective monitoring and prevention strategies are essential to mitigate these impacts, improve patient outcomes, and reduce healthcare costs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Clinical and Economic Burden of Cytomegalovirus (CMV) Infection/Disease Among Hospitalized Adult Allogeneic Hematopoietic Stem Cell Transplant (Allo‐HSCT) Recipients in China
- Date Crossref
- 01/12/2025
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Peking University pays non établi dans la noticeUniversité ou école supérieure
-
Peking University People's Hospital pays non établi dans la noticeÉtablissement de santé
-
Wuhan Union Hospital pays non établi dans la noticeÉtablissement de santé
-
Union Hospital pays non établi dans la noticeÉtablissement de santé
-
Technology Holding (United States) pays non établi dans la noticeEntreprise
-
Huazhong University of Science and Technology pays non établi dans la noticeUniversité ou école supérieure
-
Ltd Shanghai China MSD (China) Holding Co. pays non établi dans la noticeEntreprise
-
Ltd Beijing China Tianjin Happy Life Technology Co. pays non établi dans la noticeEntreprise
Peking University, Peking University People's Hospital et Wuhan Union Hospital, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.